Pandemic Control Industry - Vaccines

Home / Pandemic Control
Company Product R&D / Approval Status
Adimmune Subunit Vaccine (spike protein) Effective in the neutralization antibody assay. Phase I trials might be conducted in the third quarter of 2020.
Medigen Vaccine Biologics Subunit Vaccine (spike protein) Conducting animal studies
United Biomedical Synthetic Peptide- based Vaccines Animal testing, anticipate entering human trials in the summer.
Academia Sinica Subunit vaccine, virus-like particle, Live attenuated vaccines, nanoparticle- based vaccine Animal testing
National Health Research Institutes (NHRI) Peptide vaccine Enter human trials as early as this autumn